Caplyta 42 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6RK6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,502
Award facts
- Contract value 100% obligated
- $26,501.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $26,501.51 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units). This firm fixed-price contract, which was not set-aside and competitively awarded, was executed on December 8, 2025, with an ultimate completion date of December 9, 2025. The pharmaceuticals will be delivered to AmerisourceBergen's distribution center in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a primary vendor for the Defense Logistics Agency's medical supply chain. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. CAPLYTA is an antipsychotic medication used in the treatment of schizophrenia and bipolar disorder, reflecting the company's role in supplying psychiatric and neurological treatments to military and veteran healthcare systems. This delivery order exemplifies the ongoing pharmaceutical procurement activities conducted through DLA's established vendor relationships to ensure consistent supply of critical medications to military medical facilities.
Quick answers
Who was awarded contract SPE2DR26F6RK6?
SPE2DR26F6RK6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F6RK6 worth?
The government has obligated $26,502 on SPE2DR26F6RK6.
Is contract SPE2DR26F6RK6 an order under another contract?
Yes. SPE2DR26F6RK6 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6RK6 competed?
The extent of competition for SPE2DR26F6RK6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award